Evidence map›Paper›PMID 28825403›Full record

ArticleJournal of breath research2017

Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.

Christiaan A Rees, Pierre-Hugues Stefanuto, Sarah R Beattie, Katherine M Bultman, Robert A Cramer, Jane E Hill

Open access · greenAbstract read
In one paragraph

Article in Journal of breath research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Ethanol mediates the interaction betweenMicrobiology spectrum · 2023
    Article
  7. Article
  8. Novel Insights intoJournal of fungi (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Review
  11. Identification of Volatile Sulfur Compounds Produced byJournal of fungi (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Aspergillus fumigatus and Aspergillosis in 2019.Clinical microbiology reviews · 2019
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Christiaan A ReesGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, United States of America.ORCID 0000-0003-1896-5348
Pierre-Hugues StefanutoThayer School of Engineering, Dartmouth College, Hanover, NH 03755, United States of America.
Sarah R BeattieGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, United States of America.
Katherine M BultmanGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, United States of America.
Robert A CramerGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, United States of America.
Jane E HillGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, United States of America.
Dartmouth College · US

Funding

Molecular and Cellular Biology at DartmouthT32GM008704 · NIGMS · DARTMOUTH COLLEGE · PI COMPTON, DUANE A. · 1998 to 2018
$6.8M
TRANSLATIONAL RESEARCH COREP30GM106394 · NIGMS · DARTMOUTH COLLEGE · PI MADDEN, DEAN R · 2013 to 2017
$6.1M
HOST-MICROBE INTERACTIONST32AI007519 · NIAID · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 1997 to 2026
$5.9M
Hypoxia Adaptation and Fungal Virulence of Aspergillus fumigatusR01AI081838 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI CRAMER, ROBERT ANDREW · 2009 to 2017
$2.9M
Quantitative Biomedical Sciences at DartmouthT32LM012204 · NLM · DARTMOUTH COLLEGE · PI TOSTESON, TOR D · 2016 to 2020
$876k
NIAID NIH HHS R01 AI081838NIAID NIH HHS T32 AI007519NIGMS NIH HHS P30 GM106394NIGMS NIH HHS T32 GM008704NLM NIH HHS T32 LM012204
6 · The paper itself

Abstract

Invasive aspergillosis (IA) is a life-threatening infectious disease caused by fungi from the genus Aspergillus, with an associated mortality as high as 90% in certain populations. IA-associated pulmonary lesions are characteristically depleted in oxygen relative to normal lung tissue, and it has been shown that the most common causal agent of IA, Aspergillus fumigatus, must respond to low-oxygen environments for pathogenesis and disease progression. Previous studies have demonstrated marked alterations to the Aspergillus fumigatus transcriptome in response to low-oxygen environments that induce a 'hypoxia response'. Consequently, we hypothesized that these transcriptomic changes would alter the volatile metabolome and generate a volatile hypoxia signature. In the present study, we analyzed the volatile molecules produced by A. fumigatus in both oxygen replete (normoxia) and depleted (hypoxia) environments via headspace solid-phase micro-extraction coupled to two-dimensional gas chromatography-time-of-flight mass spectrometry. Using the machine learning algorithm random forest, we identified 19 volatile molecules that were discriminatory between the four growth conditions assessed in this study (i.e., early hypoxia (1 h), late hypoxia (8 h), early normoxia (1 h), and late normoxia (8 h)), as well as a set of 19 that were discriminatory between late hypoxia cultures and all other growth conditions in aggregate. Nine molecules were common to both comparisons, while the remaining 20 were specific to only one of two. We assigned putative identifications to 13 molecules, of which six were most highly abundant in late hypoxia cultures. Previously acquired transcriptomic data identified putative biochemical pathways induced in hypoxia conditions that plausibly account for the production of a subset of these molecules, including 2,3-butanedione and 3-hydroxy-2-butanone. These two molecules may represent a novel hypoxia fitness pathway in A. fumigatus, and could be useful in the detection of hypoxia-associated A. fumigatus lesions that develop in established IA infections.

Indexed as

MetabolomeAdaptation, PhysiologicalAspergillus fumigatusBreath TestsGas Chromatography-Mass SpectrometryHumansHypoxiaPrincipal Component AnalysisVolatile Organic CompoundsVolatile Organic Compounds

Identifiers

PMID28825403
PMCPMC5793853
OpenAlexW2692478056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.